These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24324951)

  • 21. Exhaled nitric oxide is not elevated in the inflammatory airways diseases of cystic fibrosis and bronchiectasis.
    Ho LP; Innes JA; Greening AP
    Eur Respir J; 1998 Dec; 12(6):1290-4. PubMed ID: 9877479
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical relevance of immunoglobulin subclasses in children with chronic pulmonary diseases].
    Zielen S; Wönne R; Gerein V; Kotitschke R; Zeidler R; Hofmann D
    Monatsschr Kinderheilkd; 1987 Nov; 135(11):775-9. PubMed ID: 3431558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of factors associated with bronchial hyperreactivity to methacholine in bronchiectasis.
    Ip M; Lam WK; So SY; Liong E; Chan CY; Tse KM
    Lung; 1991; 169(1):43-51. PubMed ID: 2011043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma eotaxin level and severity of asthma treated with corticosteroid.
    Tateno H; Nakamura H; Minematsu N; Nakajima T; Takahashi S; Nakamura M; Fukunaga K; Asano K; Lilly CM; Yamaguchi K
    Respir Med; 2004 Aug; 98(8):782-90. PubMed ID: 15303645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoglobulin G subclass concentrations and infections in children and adolescents with severe asthma.
    de Moraes Lui C; Oliveira LC; Diogo CL; Kirschfink M; Grumach AS
    Pediatr Allergy Immunol; 2002 Jun; 13(3):195-202. PubMed ID: 12144642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IgG subclass deficiencies associated with bronchiectasis.
    De Gracia J; Rodrigo MJ; Morell F; Vendrell M; Miravitlles M; Cruz MJ; Codina R; Bofill JM
    Am J Respir Crit Care Med; 1996 Feb; 153(2):650-5. PubMed ID: 8564113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased C-reactive protein is associated with airway wall thickness in steroid-naive asthma.
    Hoshino M; Ohtawa J; Akitsu K
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):37-41. PubMed ID: 24824230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.
    Cordova-Rivera L; Gibson PG; Gardiner PA; McDonald VM
    Respirology; 2019 Apr; 24(4):352-360. PubMed ID: 30384396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atopy, immunological changes, and respiratory function in bronchiectasis.
    Murphy MB; Reen DJ; Fitzgerald MX
    Thorax; 1984 Mar; 39(3):179-84. PubMed ID: 6710425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methotrexate as a steroid sparing agent for asthma in adults.
    Davies H; Olson L; Gibson P
    Cochrane Database Syst Rev; 2000; 1998(2):CD000391. PubMed ID: 10796540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
    Corrigan CJ; Shiner RJ; Shakur BH; Ind PW
    Clin Exp Allergy; 2005 May; 35(5):579-84. PubMed ID: 15898978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omalizumab Is Equally Effective in Persistent Allergic Oral Corticosteroid-Dependent Asthma Caused by Either Seasonal or Perennial Allergens: A Pilot Study.
    Domingo C; Pomares X; Navarro A; Rudi N; Sogo A; Dávila I; Mirapeix RM
    Int J Mol Sci; 2017 Feb; 18(3):. PubMed ID: 28264494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obesity is associated with increased asthma severity and exacerbations, and increased serum immunoglobulin E in inner-city adults.
    Fitzpatrick S; Joks R; Silverberg JI
    Clin Exp Allergy; 2012 May; 42(5):747-59. PubMed ID: 22092883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of bronchiectasis on asthma exacerbation.
    Kang HR; Choi GS; Park SJ; Song YK; Kim JM; Ha J; Lee YH; Lee BH; Kim SH; Lee JH
    Tuberc Respir Dis (Seoul); 2014 Nov; 77(5):209-14. PubMed ID: 25473408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with bronchiectasis in patients with uncontrolled asthma; the NOPES score: a study in 398 patients.
    Padilla-Galo A; Olveira C; Fernández de Rota-Garcia L; Marco-Galve I; Plata AJ; Alvarez A; Rivas-Ruiz F; Carmona-Olveira A; Cebrian-Gallardo JJ; Martinez-Garcia MA
    Respir Res; 2018 Mar; 19(1):43. PubMed ID: 29548297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. When oral corticosteroids are essential for persistent severe asthma.
    Greenberger PA
    J Allergy Clin Immunol; 2010 Feb; 125(2):511-3. PubMed ID: 20159270
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule.
    Kunkel G; Rydén AC
    Inflamm Res; 1999 Feb; 48(2):94-100. PubMed ID: 10202995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of allergic bronchopulmonary aspergillosis with central bronchiectasis over a 10-year period: the need to recheck allergen sensitization.
    Yoshida Y; Shirai T; Mikamo M; Shishido Y; Akita T; Morita S; Asada K; Fujii M; Suda T
    Intern Med; 2013; 52(18):2135-8. PubMed ID: 24042528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma.
    Wever AM; Wever-Hess J; Hermans J
    Clin Exp Allergy; 1997 May; 27(5):519-29. PubMed ID: 9179426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.